Amsterdam : Royal Philips announced its participation in the 2016 American College of Cardiology’s Annual Scientific Session and Expo (ACC.16), taking place April 2-4, 2016 in Chicago, Ill. The Philips booth (#6054) will feature innovative connected cardiology solutions to help coordinate care delivery, create individualized treatment plans and drive satisfaction among care teams and their patients, to expand quality access to care and help improve patient outcomes with the quickest path to targeted treatment. The company will also feature noted thought leaders participating in “Cardiology Talks” in the Philips booth throughout the event.
Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, and is expected to grow to more than 23.6 million by 2030. Cardiology is one of the top health technology priorities for Philips, which provides integrated solutions helping clinicians treat cardiovascular disease by speeding detection, diagnosis and treatment, driving more effective recovery and home care, and encouraging prevention and healthy living.
“The expanding profile of cardiac patients creates even more variables in diagnosis and treatment, making the need for innovative connected care solutions and customized treatment plans more crucial than ever,” said Bert van Meurs, CEO Image Guided Therapy (IGT), Philips. “One emerging area making a huge impact in interventional cardiovascular care is Image Guided Therapy. Philips is developing technology that helps clinicians decide, guide and confirm the right therapy for the right patient at the point of care. Working together with cardiology leaders in clinical studies and trials to realize this vision, we can help save and improve lives, and reduce the total cost of care by making therapy more efficient, more appropriate and more personal.”